Reinventing the pig: the negotiation of risks and rights in the USA xenotransplantation debate
by Amy L. Fletcher
International Journal of Risk Assessment and Management (IJRAM), Vol. 7, No. 3, 2007

Abstract: Xenotransplantation (XTP) involves the transplantation of cells, tissues and organs from non-human mammals (usually pigs) to humans. Because XTP could produce considerable public health gains, advocates want to proceed to human clinical trials as soon as possible. However, XTP also raises complex regulatory issues, since virtually all scientists agree that there is a risk of pig endogenous retroviruses (PERVs) crossing the species barrier and infecting patients, their contacts and potentially the community. This tension between individual benefit and potential public risk mandates that the public should be consulted on this issue. This paper analyses the XTP debate in the USA in order to evaluate the implications of the shift from expert-driven health policy to more participatory governance of health and risk.

Online publication date: Sun, 07-Jan-2007

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Risk Assessment and Management (IJRAM):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com